ReviewOphthalmology and therapy2020
Lipid Keratopathy: A Review of Pathophysiology, Differential Diagnosis, and Management.
Review in Ophthalmology and therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 31 citations in OpenAlex.
- Bilateral Lipid Keratopathy Treated with Staged Penetrating Keratoplasty: Restoration of Corneal Transparency and Visual Function.Diagnostics (Basel, Switzerland) · 2026Article
- Targeting the remodeled peritoneal ecosystem: a paradigm shift from tumor cells to the microenvironment in gastric cancer peritoneal metastasis.Frontiers in immunology · 2026Review
- Review
- Article
- Posterior corneoscleral limbus: Architecture, stem cells, and clinical implications.Progress in retinal and eye research · 2023Review
- Lipid Keratopathy: Histopathology, Major Differential Diagnoses and The Importance of Clinical Correlation.Diagnostics (Basel, Switzerland) · 2023Article
- Case report of interstitial keratitis in pregnancy.American journal of ophthalmology case reports · 2023Article
- Bilateral Lipid Keratopathy in the Setting of Brimonidine Tartrate Use.Case reports in ophthalmological medicine · 2023Article
- Cogan syndrome: a case report and review of the literature.Digital journal of ophthalmology : DJO · 2023Review
- Radiofrequency diathermy as a treatment of lipid keratopathy in a radial keratotomy incision.American journal of ophthalmology case reports · 2022Article
- Corneal thinning following bevacizumab intrastromal injection for the treatment of idiopathic lipid keratopathy.American journal of ophthalmology case reports · 2022Article
- Crystalline lipid keratopathy in anterior sclerokeratitis.BMJ case reports · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lipid keratopathy is a disease in which fat deposits accumulate in the cornea, leading to opacification and decrease of visual acuity. This condition can be idiopathic without signs of previous corneal disease or secondary to ocular or systemic diseases. Lipid keratopathy is usually associated with abnormal vascularization of the cornea, and the lipid classically deposits adjacent to these vessels. Treatment of this condition usually aims to eliminate or prevent abnormal vessel formation, and several modalities have been described. In this review we summarize the etiology, pathophysiology, and clinical presentation of lipid keratopathy and describe current and emerging treatment regimens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.